7: Obesity Flashcards

1
Q

Define NAFLD

A
  • Non-alcoholic fatty liver disease
    Presence of hepatic steatosis (fatty liver) in individuals who do not consume alcohol or do so in small quantities and who do not have another cause of secondary hepatic fat accumulation - HCV, Wilson disease, medications
  • Diagnosis of exclusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Conditions associated with NAFLD

A
○ Type 2 diabetes mellitus
		○ Overweight/obesity
		○ Hyperlipidaemia
		○ Hypertension
		○ PCOS
		○ Hypothyroidism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the difference between NAFLD and NASH?

A
  • NASH is a type of NAFLD
    • Non-alcoholic steatohepatitis
      ○ Steatohepatic injury
      ○ Fibrosis and cirrhosis
      ○ Histologically similar to alcoholic hepatitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathology of NAFLD

A
  • Precise mechanisms unknown
    • Strong association with insulin resistance
    • Insulin resistance leads to increased release of free fatty acids from adipocytes due to overactivity of lipoprotein lipase.
    • reduced production of adiponectin from adipocytes
      • decreases oxidation of free fatty acids by skeletal muscle and increases free fatty acid uptake in hepatocytes
        Hepatocytes down-regulate lipolysis,
        Fat-laden cells are highly sensitive to lipid peroxidation products generated by oxidative stress, which can damage mitochondrial and plasma membranes, potentially leading to apoptosis or necrosis
    • Dysfunctional adipocytes synthesise pro-inflammatory cytokines such as TNF-a.
    • Once cell injury becomes established, release of cytokines such as TNF-a locally from Kupffer cells leads to the activation of stellate cells, collagen deposition, and scarring
      High fructose diets have also been associated with increased risk of NAFLD-related fibrosis, and dietary fat, particularly trans-fat, may have a role in producing liver injury.
      Obstructive sleep apnoea has been associated with disease progression, possibly related to intermittent hypoxia
      Fibrosis may be accelerated when injury from another liver disease (e.g., haemochromatosis) is superimposed on NAFLD.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe and illustrate the morphology of NAFLD and NASH.

A
  • NAFLD
    ○ Hepatic steatosis - yellow enlarged appearance gross
    ○ Lipid droplets microscopically
    • NASH
      ○ Fibrosis around central vein - fine spider wed of pericellular collagen deposition
      ○ Ballooned hepatocytes
      ○ Mallory-Dank bodies - complex of misfolded cytoskeletal elements
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the consequences of disease progression of NAFLD

A
- Hepatic complications:
		○ Liver fibrosis and cirrhosis
		○ Portal hypertension
		○ Variceal haemorrhages
		○ Hepatocellular carcinoma
		○ Liver transplant
	- Others:
	- Increased risk of
		○ Type 2 diabetes (2-fold increase)
		○ Hypertension
Chronic kidney disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the pathogenesis of acute cholecystitis?

A
  • 90% of cases caused by obstruction of neck of gallbladder or cystic duct by a stone
    • Chemical irritation and inflammation of gallbladder obstructed by stones
    • Mucosal phospholipases hydrolyses luminal lecithins to toxic lysolecithins
    • Normally protective glycoprotein mucus layer is disrupted exposing mucosal epithelium to detergent action of bile salts
    • Prostaglandins released contribute to mucosal and mural inflation
    • Distention of gallbladder and increased intraluminal pressure compromise blood flow to mucosa
    • Initially occur in absence of bacterial infection but later bacterial infection may be superimposed and exacerbate inflammatory process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Morphology of cholecystitis

A
  • Gross
    ○ Enlarged and tense gallbladder
    ○ Bright red or blotchy, violaceous to green-black discolouration imparted by subseral haemorrhages
    ○ Serosa covered by fibrinous exudate
    ○ Obstructing stone present in neck of gallbladder of cystic duct
    ○ Gallbladder lumen contains more stones
    ○ Filled with cloudy, or turbid bile mixed with fibrin, pus and haemorrhage
    ○ Gallbladder empyema - exudate pure pus
    ○ Gangrenous cholecystitis - green-black necrotic organ with perforations
    • Histologically
      ○ Early changes
      § Oedema
      § Congestions
      § Mucosal erosion
      Neutrophils sparse unless superimposed infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical features of cholecystitis

A
  • RUQ or epigastric pain
    • Associated with
      ○ Mild fever
      ○ Anorexia
      ○ Tachycardia
      ○ Sweating
      ○ N+V
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In what circumstances may an individual suffer cholecystitis in the absence of gallstones?

A
  • Acute acalculous cholecystitis
    • Ischaemia
    • Cystic artery end artery without collateral circulation
    • Risk factors
      ○ Sepsis with hypotension and multisystem organ failure
      ○ Immunosuppression
      ○ Major trauma and burns
      ○ Diabetes mellitus
      ○ Infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the pathogenesis of chronic cholecystitis?

A

Sequel to repeated bouts of mild to severe acute cholecystitis or develops in absence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Morphology of chronic cholecystitis

A
- Gross
		○ Subserosal fibrosis
		○ Dense fibrous adhesions
		○ Wall thickened
		○ Opaque grey-white appearance
	- Histological
		○ Scattered lymphocytes, plasma cells and macrophages in mucosa and subserosa fibrosis tissue
		○ Marked subepithelial and subserosa fibrosis with mononuclear cell infiltration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical features of chronic cholecystitis

A
  • Recurrent attacks of either steady epigastric or RUQ pain
    • N+V
      Intolerance to fatty foods
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What complications can arise from acute and chronic cholecystitis?

A
  • Bacterial superinfection with cholangitis or sepsis
    • Gallbladder perforation and local abscess formation
    • Gallbladder rupture with diffuse peritonitis
    • Biliary enteric (cholecystenteric) fistula, with drainage of bile into adjacent organs, entry of air and bacteria into the biliary tree, and potentially, gallstone-induced intestinal obstruction (ileus)
    • Aggravation of pre-existing medical illness, with cardiac, pulmonary, renal, or liver decompensation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Classification of gallstones

A
  • Cholesterol gallstone
    ○ Western populations
    ○ Located in gallbladder
    ○ 10-20% radiopaque
    ○ Mostly cholesterol
    • Mixed gallstones
    • Pigment gallstones
      ○ Non-western populations
      ○ Located in gallbladder (black) and large bile ducts (brown)
      ○ 50-75% of black are radiopaque and all brown are radiolucent
      ○ Consist of calcium, phosphate, bilirubin and bile acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk factors for cholesterol gallstones

A
§ Gall bladder hypomotility
				□ Vagotomy
				□ Octreotide
				□ Prolonged fasting
			§ Supersaturated bile
				□ Increased age
				□ Female
				□ Genetics
				□ Obesity
				□ Drugs
				□ Diet
				□ Liver disease
				□ Pregnancy
			§ Mucin hypersecretion
				□ Infection
			§ Decreased bile salt excretion
				□ Bowel transit time
				□ Ileal resection
				□ Crohn's
				□ Cholestyramine
				□ Faecal flora
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pathogenesis of cholesterol gallstones

A

○ Pathogenesis
§ Soluble micelles
§ Nucleation into solid crystals when bile is supersaturated
§ Crystals trapped by mucus to form macroscopic stones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Risk factors for pigment gallstones

A
□ Haemolysis
				□ Ineffective erythropoiesis
				□ Mucin hypersecretion
					® Infection 
				□ Gallbladder hypomotility
					® Vagotomy
					® Octreotide
					® Prolonged fasting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Risk factors of pigment gallstones

A
Black pigment stones
				□ Haemolysis
				□ Ineffective erythropoiesis
				□ Mucin hypersecretion
					® Infection 
				□ Gallbladder hypomotility
					® Vagotomy
					® Octreotide
				□ Prolonged fasting
Brown pigment stones
				□ E.coli infection
				□ Lumbricids
				□ C.sinensis
				□ Mucin hypersecretion
					->Infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pathogenesis of pigment gallstones

A
Black pigment stones
				□ Bilirubin overproduction
				□ Increased unconjugated bilirubin
				□ Precipitation of pigment
				□ Black pigment stones
Brown pigment stones
				□ Bacterial contamination
				□ Conjugated bilirubin hydrolysis
				□ Increased unconjugated bilirubin
				□ Precipitation of pigment
				□ Brown pigment stones
21
Q

Morphological features of gallstones

A
- Macro
		○ Cholesterol = yellow
		○ Pigmented = black/brown
	- Micro
		○ Laminae propria distended by foamy macrophages
22
Q

Complications of gallstones

A
  • Asymptomatic stone in 75%
    • Biliary colic - 20%
    • Acute cholecystitis - 10%
    • Cholecystitis
    • Mirizzi syndrome
    • Gallbladder carcinoma
    • Pancreatitis
    • Ascending cholangitis
    • Cholecystoenteric fistula +- gallstone ileus
23
Q

Risk factors for gallbladder carcinoma

A
○ Chronic inflammation
			§ Cholesterone gallstones
			§ Primary sclerosing cholangitis
			§ Inflammatory bowel disease
			§ Chronic infection
		○ Chronic chemical injury
			§ Congenital defects
				□ Abnormal pancreatic-biliary duct junctions
		○ Hereditary mutations
			§ Gardner syndrome
			§ HNPCC
			§ Neurofibromatosis type 1
			§ Other specific mutations
24
Q

Pathogenesis of gallbladder carcinoma

A
○ Chronic insult to normal epithelium
		○ Proliferation  and mutation
		○ Metaplasia
		○ Dysplasia
		○ Carcinoma in situ
		○ Invasive carcinoma
		○ Progression over 20-30 years
25
Q

Morphology of gallbladder carcinoma

A

○ Macro
§ Large mass filling lumen
§ Multifocal and nodular
§ Arising from polyp
§ Diffusely thickened wall
§ Firm, gritty, tan-white to yellow-grey cut surface
§ 60% occur in fundus, 30% in body and 10% in neck
○ Micro
§ Biliary type adenocarcinoma = 75%
□ Tubules lined by cuboidal to columnar cells embedded in desmoplastic stoma

26
Q

How are malignant biliary tumours classified?

A
  • Intrahepatic cholangiocarcinoma
    • Extrahepatic cholangiocarcinoma
      ○ Hilar cholangiocarcinoma
      ○ Distal cholangiocarcinoma
27
Q

Risk factors in biliary tumours

A
- Developmental disorders
		○ Fibropolycycstic liver disease
	- Chronic inflammation
		○ Primary sclerosing cholangitis
		○ Infestation by liver flukes
		○ Hepatolithiasis
	- Chronic liver disease
		○ Hepatitis B and C
		○ Non-alcoholic fatty liver disease
	- Acquired driver mutations due to chronic injury, inflammation and regeneration
28
Q

Morphological features of biliary tumours

A
- Gross
		○ Mass forming
		○ Periductal infiltration
		○ Intraductal growing
		○ White-yellow on cut section
	- Micro
		○ Invasive malignant glands
		○ Reactive, sclerotic stroma
		○ Circumferential malignant glands
		○ Central, trapped nerve
29
Q

What are the aetiologic factors in acute pancreatitis?

A
- Metabolic
		○ Alcoholism
		○ Hyperlipoproteinemia
		○ Hypercalcaemia
	- Drugs 
		○ Azathioprine
		○ Statins
		○ GLP-1 agonist
		○ DPP-4 inhibitors
	- Genetic
		○ Mutations in genes encoding for
			§ Trypsin
			§ Trypsin regulators
			§ Proteins that regulate calcium metabolism
		○ Cystic fibrosis
	- Mechanical
		○ Gallstones
		○ Trauma
		○ Iatrogenic injury
			§ Operative
			§ ERCP
	- Vascular
		○ Shock
		○ Atheroembolism
		○ Vasculitis
	- Infectious
		○ Mumps
		○ Coxsackievirus
30
Q

Pathogenesis of acute pancreatitis

A
  • Pancreatic duct obstruction
    ○ Gallstones, biliary sludge
    ○ Increased intrahepatic ductal pressure
    ○ Fluid/enzymes leak into interstitium
    ○ Lipase damages adipocytes -> inflammation
    ○ Oedema compromises blood flow
    ○ Vascular insufficiency ->ischaemic injury -> inflammation
    • Primary acinar cell injury
      ○ Alcohol, drugs, trauma, infection, vascular
      ○ Causes release of digestive enzymes -> autodigestion -> inflammation
      ○ Oxidative stress -> inflammation
      ○ Calcium influx - trypsin autoactivates when Ca2+ high
    • Mixing of proenzymes and hydrolases inside acinar cells
31
Q

How is alcohol thought to induce pancreatitis?

A
  • Duct obstruction
    • Increases contractility of sphincter of Oddi
      ○ Chronic alcoholism causes release of protein-rich fluid which plugs small pancreatic ducts
    • Acinar cell damage
      ○ Oxidative stress: causes inflammation and activates proenzymes
      ○ Mitochondrial damage; increases intracellular Ca2+
32
Q

Morphology of acute pancreatitis

A
  • Microvascular leak and oedema
    • Fat necrosis
    • Acute inflammation
    • Parenchymal damage including autodigestion
    • Blood vessel destruction, haemorrhage
33
Q

Clinical features of acute pancreatitis

A
  • Upper abdominal pain
    ○ Mid-epigastric, LUQ, radiates to back
    ○ Sudden onset esp. gallstone pancreatitis. Constant and severe.
    ○ Worse with movement
    ○ Most Pts present within 12-24 hours of symptom onset
    • Nausea and vomiting
    • Dyspnoea (pain, effusion, ARDS)
    • Agitation, confusion
    • Diagnosis (2 of 3)
      ○ Upper abdominal pain
      ○ Elevated serum lipase or amylase (may have returned to normal if presentation delayed)
      ○ Imaging findings
34
Q

Complications of acute pancreatitis

A
○ AKI/ acute kidney failure
		○ Sepsis
			§ Gram negative organisms
		○ ARDS
		○ Pancreatic pseudocyst
		○ Chronic pancreatitis
		○ Pancreatic abscess
35
Q

Complications of ERCP

A
  • Pancreatitis (5%)
    • Haemorrhage
    • Perforation
    • Infection
    • Oesophageal/gastric injury
    • 30-day mortality 0.5-1%.
36
Q

Physiological changes in adipose tissue in obesity

A
  • Active endocrine organ
    ○ Able to synthesise and release adipokines
    • Obesity has a strong genetic predisposition, and results from an excess energy intake and/or too little energy expenditure.
      ○ Dominant changes seen
      ○ Chronic inflammation
      ○ Changes in secretory function of adipocytes and macrophages
      ○ Inappropriate extracellular matrix remodelling
      ○ Insufficient angiogenic potential
37
Q

Development of pro-inflammatory state in obesity

A
  • In positive energy balance undergoes maladaptive expansion
    ○ Adipocyte hyperplasia and hypertrophy
    ○ Localised hypoxia and ischaemic necrosis
    ○ Inflammatory response
    ○ Cell death stimulates infiltration by activated macrophages
    • Changes in composition and phenotypes of cells
      ○ Polarisation of resident adipose tissue macrophages towards pro-inflammatory phenotype
      ○ Activate inflammatory pathways
    • Development of a chronic low inflammatory state
38
Q

Pathophysiological effects of adipokines

A
  • Adipokine dysregulation = imbalance between pro and anti-inflammatory compounds in favour of the pro-inflammatory ones
    • Under conditions of normal energy balance adipocytes predominately secrete anti-inflammatory adipokines
      ○ Adiponectin
      ○ Transforming growth factor β (TGF-β)
      ○ Interleukin 10 (IL-10)
      ○ Secreted frizzled-related protein 5 (SFRP5)
      ○ Nitric oxide (NO)
    • Promote insulin sensitivity and exert cardioprotective and anti-atherogenic effects
    • Dysfunctional hypertrophic adipocytes produce and release pro-inflammatory adipokines
      ○ Leptin
      ○ Tumour necrosis factor α (TNF-α)
      ○ Interleukin 6 (IL-6)
      ○ Interleukin 18 (IL-18)
      ○ Resistin
      ○ Retinol binding protein 4 (RBP-4)
      ○ Lipocalin 2
      ○ Angiopoietin-like protein 2 (ANGPTL2)
    • Exert atherogenic effects
    • Hyperleptinemia ( result of both excess AT and hypothalamic leptin resistance) associated with adverse CVD outcomes – through vascular inflammation, oxidative stress, atherothrombosis, LV hypertrophy and systemic insulin resistance
39
Q

Fat storage locations

A
  • More than 80% of adipose tissue is found subcutaneously – mainly in abdominal and gluteofemoral regions
    • Visceral adipose tissue represents the majority of remaining
    • Strong link between visceral obesity and constellation of risk factors
      ○ Insulin resistance
      ○ Atherogenic dyslipidaemia
      ○ Hypertension
      ○ Increased overall CVD risk
    • Peripheral fat deposition has a favourable impact on CVD risk
    • In positive energy balance excess energy channelled into insulin sensitive subcutaneous adipose tissue (SAT)
      ○ Expands through hyperplasia to accommodate increased energy
    • If SAT is absent triglyceride or threshold reached surplus deposited in abnormal sites
    • Excessive intra-organ and peri-organ fat associated with:
      ○ Insulin resistance
      ○ Systemic inflammation
      ○ Cardiovascular dysfunction
40
Q

Impact of fat location on CVS

A
  • Intramyocardial fat within cardiomyocytes
    • Epicardial fat on surface of myocardium
      ○ PVAT = Adipose tissue surrounds major conduit coronary arteries
    • Pericardial fat located between parietal and visceral pericardium
    • Paracardial fat located outside pericardium
    • PVAT secretes
      ○ Leptin
      ○ Adiponectin
      ○ Resistin
      ○ Visfatin
      ○ Chemerin
      ○ TNF-α
      ○ IL-6
      ○ IL-18
      ○ Monocyte Chemoattractant Protein 1
      ○ (MCP-1)
      ○ Plasminogen Activator Inhibitor Type 1 (PAI-1)
    • Modulate vascular tone, smooth muscle cell migration and proliferation, neointimal formation, inflammation and oxidative stress
    • In obesity PVAT becomes enlarged and dysfunctional
    • Imbalance between vasorelaxant and vasoconstrictor factors in favour of vasoconstrictor and pro-inflammatory ones
    • Associated with
      ○ Adverse vascular remodelling
      ○ Vascular inflammation
      ○ Oxidative stress
      ○ Insulin resistance
    • Leading to decreased NO bioavailability
    • Secretion pro-inflammatory adipokines that induce endothelial dysfunction and infiltration of inflammatory cells, promoting atherosclerosis development
    • Atherosclerosis of coronary arteries
41
Q

Features of OSA

A

Obstructive sleep apnoea
- Recurrent episodes of obstruction in the upper airway leading to sleep fragmentation and intermittent hypoxia during sleep
- Caused by
○ Upper airway obstruction due to facial fat
○ Reduced lung volume due to increased abdominal fat

42
Q

Pathological impact of OSA

A
○ Hypoxemia
		○ Hypercapnia
		○ Hyperactive sympathetic system - increased BP
		○ Endothelial dysfunction
		○ Systemic inflammation
		○ Metabolic dysfunction - Increased insulin resistance
		○ Increased risk for
			§ Stroke
			§ Heart failure
			§ Type 2 DM
			§ MI
			§ AF
			§ Death
43
Q

Define obesity hypoventilation syndrome.

A
  • Obese patient with sleep-disordered breathing in absence of any other causes of hypoventilation such as COPD
    • Pyramid of
      ○ Daytime hypercapnia
      ○ Hypoxaemia
      ○ Hypoventilation
44
Q

How does obesity hypoventilation syndrome cause death

A
  • Impaired ventilation mechanisms
    • Hypoxaemia, hypercapnia and acidosis
    • Pulmonary vasoconstriction
    • Pulmonary hypertension
    • Cor-pulmonary
    • Sudden death due to acute decompensation or lethal ventricular arrythmia
45
Q

How does OSA lead to death

A
- Leads to death by
		○ Recurrent apnoea
		○ Chronic alveolar hypoxia
		○ Pulmonary artery constriction
		○ Pulmonary hypertension
		○ Cor pulmonale and left ventricular failure
		○ Congestive heart failure
46
Q

What are the haemodynamic effects of obesity on the heart and how do these effects contribute to cardiac dysfunction?

A
  • Excess Adipose Tissue
    • Increased Metabolic Activity
    • Increase in blood volume and cardiac output
    • Ventricular dilatation
    • Left and right ventricular hypertrophy with systolic dysfunction
    • Congestive Heart Failure
47
Q

What are the criteria diagnosing death due to obesity cardiomyopathy?

A
  • Heart weight increased over value predicted for normal body weight.
    • Left ventricular or biventricular hypertrophy and dilatation of atria and ventricles.
    • Presence of fat in the right ventricle with the absence of fibrosis.
    • Exclusion of significant coronary artery disease, myocarditis, myocardial infarction or other cause of death
48
Q

What are the common cardiac arrhythmias associated with sudden death in obesity?

A
  • Prolonged QT interval
    • AF
    • Premature ventricular ectopic - can lead to tachyarrhythmias and increased mortality